Company intelligence / Profile preview
Shanghai Minbiotech
- Ownership
- Private
- Employees
- ~60
- Development stage
- Other
Overview
Shanghai Minbiotech is an established producer of advanced pharmaceutical intermediates, biological APIs, and a variety of high-end generic and innovative drugs. It is active in supplying compliant, high-quality pharmaceutical ingredients trusted by global clients, including specialty antibiotics such as polymyxin B. The company has a diverse production portfolio and is equipped for R&D and manufacturing of both biologics and small molecules.
- Therapeutic areas
- Infectious Diseases
- Modalities
- BiologicSmall molecule
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Shanghai Minbiotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Minbiotech.